drugset / Trial / NCT01121198

A Study to Assess Safety and Tolerability of ASP1941 After Single and Repeated Administration in Healthy Subjects

NCT01121198

Phase 1 Completed 84 enrolled Astellas Pharma Inc
RandomizedParallel-groupSingle-blind

Summary

This study is to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of ASP1941 in healthy adult male subjects.

Timeline

Start
2006-12
Primary completion
2007-07
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject ipragliflozin Small molecule Oral

Indications

No indication recorded.